Genetics and pharmacogenetics of the leukotriene pathway

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 3, 2009, Pages 422-427

  Tantisira, Kelan G ^a   Drazen, Jeffrey M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

5 lipoxygenase; asthma; Leukotrienes; montelukast; pharmacogenetics; single nucleotide polymorphism; zileuton

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; LEUKOTRIENE; LEUKOTRIENE C4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MONTELUKAST; PEPTIDOLEUKOTRIENE; PLACEBO; THEOPHYLLINE; ZILEUTON;

ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG METABOLISM; DRUG RESPONSE; ENZYME INHIBITION; FORCED EXPIRATORY VOLUME; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOPATHOGENESIS; LOW DRUG DOSE; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; PROMOTER REGION; RESPIRATORY TRACT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTI-ASTHMATIC AGENTS; ARACHIDONATE 5-LIPOXYGENASE; ASTHMA; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; RECEPTORS, LEUKOTRIENE;

EID: 69349086363     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.06.035     Document Type: Article

References (24)

1. Werz O., and Steinhilber D. Therapeutic options for 5-lipoxygenase inhibitors. Pharmacol Ther 112 (2006) 701-718
2. Szefler S.J., Phillips B.R., Martinez F.D., Chinchilli V.M., Lemanske R.F., Strunk R.C., et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 115 (2005) 233-242
3. Drazen J.M., Silverman E.K., and Lee T.H. Heterogeneity of therapeutic responses in asthma. Br Med Bull 56 (2000) 1054-1070
4. Masoli M., Fabian D., Holt S., and Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59 (2004) 469-478
5. Kedda M.A., Shi J., Duffy D., Phelps S., Yang I., O'Hara K., et al. Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma. J Allergy Clin Immunol 113 (2004) 889-895
6. Holloway J.W., Barton S.J., Holgate S.T., Rose-Zerilli M.J., and Sayers I. The role of LTA4H and ALOX5AP polymorphism in asthma and allergy susceptibility. Allergy 63 (2008) 1046-1053
7. Kalayci O., Birben E., Sackesen C., Keskin O., Tahan F., Wechsler M.E., et al. ALOX5 promoter genotype, asthma severity and LTC production by eosinophils. Allergy 61 (2006) 97-103
8. Thompson M.D., Capra V., Takasaki J., Maresca G., Rovati G.E., Slutsky A.S., et al. A functional G300S variant of the cysteinyl leukotriene 1 receptor is associated with atopy in a Tristan da Cunha isolate. Pharmacogenet Genomics 17 (2007) 539-549
9. Pillai S.G., Cousens D.J., Barnes A.A., Buckley P.T., Chiano M.N., Hosking L.K., et al. A coding polymorphism in the CYSLT2 receptor with reduced affinity to LTD4 is associated with asthma. Pharmacogenetics 14 (2004) 627-633
10. Hong X., Zhou H., Tsai H.J., Wang X., Liu X., Wang B., et al. Cysteinyl leukotriene receptor 1 gene variation and risk of asthma. Eur Respir J 33 (2009) 42-48
11. Israel E., Fischer A.R., Rosenberg M.A., Lilly C.M., Callery J.C., Shapiro J., et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis 148 (1993) 1447-1451
12. Settipane G.A., and Pudupakkam R.K. Aspirin intolerance. III. Subtypes, familial occurrence, and cross-reactivity with tartarazine. J Allergy Clin Immunol 56 (1975) 215-221
13. Choi J.H., Park H.S., Oh H.B., Lee J.H., Suh Y.J., Park C.S., et al. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet 114 (2004) 337-344
14. Kim S.H., Oh J.M., Kim Y.S., Palmer L.J., Suh C.H., Nahm D.H., et al. Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males. Clin Exp Allergy 36 (2006) 433-439
15. Park J.S., Chang H.S., Park C.S., Lee J.H., Lee Y.M., Choi J.H., et al. Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet Genomics 15 (2005) 483-492
16. Mougey E.B., Feng H., Castro M., Irvin C.G., and Lima J.J. Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenet Genomics 19 (2009) 129-138
17. Niemi M. Role of OATP transporters in the disposition of drugs. Pharmacogenomics 8 (2007) 787-802
18. Drazen J.M., Yandava C.N., Dube L., Szczerback N., Hippensteel R., Pillari A., et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet 22 (1999) 168-170
19. Lima J.J., Zhang S., Grant A., Shao L., Tantisira K.G., Allayee H., et al. Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med 173 (2006) 379-385
20. Telleria J.J., Blanco-Quiros A., Varillas D., Armentia A., Fernandez-Carvajal I., Jesus Alonso M., et al. ALOX5 promoter genotype and response to montelukast in moderate persistent asthma. Respir Med 102 (2008) 857-861
21. Drazen J.M., Yandava C.N., Dube L., Szczerback N., Hippensteel R., Pillari A., et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet 22 (1999) 168-170
22. Klotsman M., York T.P., Pillai S.G., Vargas-Irwin C., Sharma S.S., van den Oord E.J., et al. Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast. Pharmacogenet Genomics 17 (2007) 189-196
23. Tantisira K.G., Lima J., Sylvia J., Klanderman B., and Weiss S.T. 5-Lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci. Pharmacogenet Genomics 19 (2009) 244-247
24. Kawagishi Y., Mita H., Taniguchi M., Maruyama M., Oosaki R., Higashi N., et al. Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. J Allergy Clin Immunol 109 (2002) 936-942